Veterinary Medicine Information website

Trilotab 30 mg chewable tablets for dogs

Authorised
  • Trilostane
Download as PDF

Product identification

Medicine name:
Trilotab 30 mg chewable tablets for dogs
Active substance:
  • Trilostane
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Trilostane
    30.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Chewable tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH02CA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Available in:
  • Latvia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)
Marketing authorisation holder:
  • CP-Pharma Handelsgesellschaft mbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • CP-Pharma Handelsgesellschaft mbH
  • Symbiotica Speciality Ingredients Sdn. Bhd.
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/DCP/23/0040
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0373/002
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Poland
  • Portugal
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 22/08/2023
Updated on: 13/03/2026
Download
Latvian (PDF)
Published on: 7/04/2026
Download

PuAR Trilotab NL_V_0373_001-005_DC 2023-08.pdf

English (PDF)
Published on: 25/08/2023
Updated on: 13/03/2026
Download